BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 720076)

  • 1. Clinical chemistry in women treated with progestogen implants.
    Croxatto HB; Diaz S; Pavez M
    Contraception; 1978 Oct; 18(4):441-50. PubMed ID: 720076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with implant contraception.
    Coutinho E
    Contraception; 1978 Oct; 18(4):411-27. PubMed ID: 720074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial with subdermal implants containing norgestrienone.
    Diaz S; Pavez M; Quinteros E; Diaz J; Robertson DN; Croxatto HB
    Contraception; 1978 Oct; 18(4):429-40. PubMed ID: 720075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraception with long acting subdermal implants: I. An effective and acceptable modality in international clinical trials.
    Coutinho E; da Silva AR; Mattos CE; Nielsen NC; Osler M; Wiese J
    Contraception; 1978 Oct; 18(4):315-33. PubMed ID: 363345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year contraception with norgestrienone subdermal silastic implants.
    Coutinho EM; da Silva AR
    Fertil Steril; 1974 Feb; 25(2):170-6. PubMed ID: 4811085
    [No Abstract]   [Full Text] [Related]  

  • 6. Three-year experience with NORPLANT subdermal contraception.
    Sivin I; Sanchez FA; Diaz S; Holma P; Coutinho E; McDonald O; Robertson DN; Stern J
    Fertil Steril; 1983 Jun; 39(6):799-808. PubMed ID: 6406273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-year clinical trial with levonorgestrel silastic implants.
    Diaz S; Pavez M; Robertson DN; Croxatto HB
    Contraception; 1979 Jun; 19(6):557-73. PubMed ID: 385243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal implants: contraception for a new century.
    Darney PD
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long acting contraceptive implants. An analysis of menstrual bleeding patterns.
    Faundes A; Sivin I; Stern J
    Contraception; 1978 Oct; 18(4):355-65. PubMed ID: 363347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone-releasing silicone-rubber intrauterine contraceptive devices. Effect of incorporation of various compounds on intrauterine contraceptive devices in rats.
    Doyle LL
    Am J Obstet Gynecol; 1975 Feb; 121(3):405-11. PubMed ID: 1115155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraception by intradermal implants.
    Res Reprod; 1979 May; 11(3):1-2. PubMed ID: 12335899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a once-a-week steroid contraceptive (R2323) on lipid and carbohydrate metabolism in women during three months of use.
    Spellacy WN; Buhi WC; Dumbaugh VA; Birk SA
    Fertil Steril; 1978 Sep; 30(3):289-92. PubMed ID: 710600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraception with long acting subdermal implants: II. Measured and perceived effects in international clinical trials.
    Coutinho E; da Silva AR; Mattos CE; Nielsen NC; Osler M; Wiese J
    Contraception; 1978 Oct; 18(4):335-53. PubMed ID: 363346
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial with subdermal implants of the progestin R-2323.
    Diaz S; Pavez M; Quniteros E; Robertson DN; Croxatto HB
    Contraception; 1977 Aug; 16(2):155-65. PubMed ID: 913113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new delivery system for contraceptive steroids.
    Segal S
    Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 2):1090-2. PubMed ID: 3118719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norplant: reversible implant contraception.
    Sivin I; Robertson DN; Stern J; Croxatto HB; Diaz S; Coutinho E; da Silva AR; Alvarez Sanchez F; Faundes A; McDonald O; Holma P; Nielsen NC; Osler M; Nash HA
    Stud Fam Plann; 1980; 11(7-8):227-35. PubMed ID: 6996230
    [No Abstract]   [Full Text] [Related]  

  • 17. Unaltered lipoprotein and carbohydrate metabolism during treatment with contraceptive subdermal implants containing ST-1435.
    Odlind V; Lithell H; Selinus I; Vessby B
    Ups J Med Sci; 1984; 89(2):151-8. PubMed ID: 6380075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum lipids, blood pressure, body weight, and serum chemistry in women using subcutaneous contraceptive implants releasing the progestin ST 1435.
    Laurikka-Routti M
    Obstet Gynecol; 1992 Nov; 80(5):855-9. PubMed ID: 1407928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravaginal contraception with the synthetic progestin, R2010.
    Toivonen J
    Contraception; 1979 Nov; 20(5):511-8. PubMed ID: 527342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
    Olsson SE
    Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.